Brexit – The Consequences for Pharmaceutical Patents and Supplementary Protection Certificates
Now that the UK has left the EU, and the transition period following this departure is over, we have a clearer view on the implications of Brexit on intellectual property rights and the consequences for UK based pharmaceutical companies. Although little has changed for UK applicants wishing to obta...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
University of Huddersfield Press
2021-05-01
|
Series: | British Journal of Pharmacy |
Subjects: | |
Online Access: | https://www.bjpharm.org.uk/article/id/896/ |